A couple of things about Cpn10. The original trials were not done under US IND so new safety data is required. There was only a limited amount of drug scrounged by the new management, so a large trial was not possible. They need a new supply of drug which requires a lot of capital. The management are doing a very good job with what is available. The results will be positive.
- Forums
- ASX - By Stock
- What's the next significant announcement ?
A couple of things about Cpn10. The original trials were not...
Featured News
Add IVX (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.91M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.61K | 536.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 2348301 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 11132211 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 2348301 | 0.003 |
29 | 33304015 | 0.002 |
18 | 20233817 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 11132211 | 12 |
0.005 | 8438292 | 24 |
0.006 | 4548562 | 12 |
0.007 | 1780119 | 4 |
0.008 | 4405000 | 5 |
Last trade - 12.22pm 16/08/2024 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online